Chemed Shares Fall On Earnings Miss, Executive Departure

Dow Jones

2025/07/30

By Nicholas G. Miller

Chemed shares fell in late trading after the company reported second-quarter earnings well below Wall Street's expectations and said that the chief executive of one of its subsidiaries was leaving.

The stock was down 5.3% to $440 in after-hours trading and is down 18% over the last 12 months.

The company, which operates a hospice-care provider and a plumbing company, reported $4.27 in adjusted earnings per share, well below Wall Street's expectation of $5.24 a share.

The company lowered its full-year earnings guidance to be between $22 and $22.30 a share. It previously forecasted $24.95 to $25.45 a share.

The company said Nicholas Westfall, CEO of VITAS, the hospice-care provider, was leaving the company and would be replaced by current VITAS Chief Operating Officer Joel Wherley. Westfall will remain with the company until Dec. 1.

Write to Nicholas G. Miller at nicholas.miller@wsj.com.

(END) Dow Jones Newswires

July 29, 2025 17:54 ET (21:54 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2555621700"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2555621700\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2555621700?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-30 05:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2555621700","market":"fut","top_or_hot":-1,"title":"Chemed Shares Fall On Earnings Miss, Executive Departure","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Nicholas G. <a href=\"https://laohu8.com/S/MLR\">Miller</a> \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/CHE\">Chemed</a> shares fell in late trading after the company reported second-quarter earnings well below Wall Street's expectations and said that the chief executive of one of its subsidiaries was leaving. \n</p>\n<p>\n  The stock was down 5.3% to $440 in after-hours trading and is down 18% over the last 12 months. \n</p>\n<p>\n  The company, which operates a hospice-care provider and a plumbing company, reported $4.27 in adjusted earnings per share, well below Wall Street's expectation of $5.24 a share. \n</p>\n<p>\n  The company lowered its full-year earnings guidance to be between $22 and $22.30 a share. It previously forecasted $24.95 to $25.45 a share. \n</p>\n<p>\n  The company said Nicholas Westfall, CEO of VITAS, the hospice-care provider, was leaving the company and would be replaced by current VITAS Chief Operating Officer Joel Wherley. Westfall will remain with the company until Dec. 1. \n</p>\n<p>\n  Write to Nicholas G. Miller at nicholas.miller@wsj.com. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 29, 2025 17:54 ET (21:54 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chemed Shares Fall On Earnings Miss, Executive Departure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChemed Shares Fall On Earnings Miss, Executive Departure\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-07-30 05:54</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Nicholas G. <a href=\"https://laohu8.com/S/MLR\">Miller</a> \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/CHE\">Chemed</a> shares fell in late trading after the company reported second-quarter earnings well below Wall Street's expectations and said that the chief executive of one of its subsidiaries was leaving. \n</p>\n<p>\n  The stock was down 5.3% to $440 in after-hours trading and is down 18% over the last 12 months. \n</p>\n<p>\n  The company, which operates a hospice-care provider and a plumbing company, reported $4.27 in adjusted earnings per share, well below Wall Street's expectation of $5.24 a share. \n</p>\n<p>\n  The company lowered its full-year earnings guidance to be between $22 and $22.30 a share. It previously forecasted $24.95 to $25.45 a share. \n</p>\n<p>\n  The company said Nicholas Westfall, CEO of VITAS, the hospice-care provider, was leaving the company and would be replaced by current VITAS Chief Operating Officer Joel Wherley. Westfall will remain with the company until Dec. 1. \n</p>\n<p>\n  Write to Nicholas G. Miller at nicholas.miller@wsj.com. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 29, 2025 17:54 ET (21:54 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CHE","symbol_name":"Chemed Corp","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2555621700","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2555621700","pubTimestamp":1753826040,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Chemed shares fell in late trading after the company reported second-quarter earnings well below Wall Street's expectations and said that the chief executive of one of its subsidiaries was leaving.The stock was down 5.3% to $440 in after-hours trading and is down 18% over the last 12 months.The company, which operates a hospice-care provider and a plumbing company, reported $4.27 in adjusted earnings per share, well below Wall Street's expectation of $5.24 a share.The company lowered its full-year earnings guidance to be between $22 and $22.30 a share. It previously forecasted $24.95 to $25.45 a share.The company said Nicholas Westfall, CEO of VITAS, the hospice-care provider, was leaving the company and would be replaced by current VITAS Chief Operating Officer Joel Wherley. Westfall will remain with the company until Dec. 1.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"CHE":"Chemed Corp"},"translate_title":"Chemed股价因盈利未达预期和高管离职而下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CHE":1},"content_text":"By Nicholas G. Miller\n\n\nChemed shares fell in late trading after the company reported second-quarter earnings well below Wall Street's expectations and said that the chief executive of one of its subsidiaries was leaving. \n\n\n  The stock was down 5.3% to $440 in after-hours trading and is down 18% over the last 12 months. \n\n\n  The company, which operates a hospice-care provider and a plumbing company, reported $4.27 in adjusted earnings per share, well below Wall Street's expectation of $5.24 a share. \n\n\n  The company lowered its full-year earnings guidance to be between $22 and $22.30 a share. It previously forecasted $24.95 to $25.45 a share. \n\n\n  The company said Nicholas Westfall, CEO of VITAS, the hospice-care provider, was leaving the company and would be replaced by current VITAS Chief Operating Officer Joel Wherley. Westfall will remain with the company until Dec. 1. \n\n\n  Write to Nicholas G. Miller at nicholas.miller@wsj.com. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 29, 2025 17:54 ET (21:54 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}